Published in J Virol on August 01, 2004
Crystal structure of the West Nile virus envelope glycoprotein. J Virol (2006) 2.61
Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology (2008) 1.89
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol (2009) 1.65
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog (2009) 1.36
Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur Biophys J (2007) 1.29
Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. J Cell Biol (2005) 1.25
Flaviviruses: braking the entering. Curr Opin Virol (2013) 1.02
Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect (2010) 1.00
Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes. Antimicrob Agents Chemother (2013) 0.90
Sequential conformational rearrangements in flavivirus membrane fusion. Elife (2014) 0.88
Membrane lipids influence protein complex assembly-disassembly. J Am Chem Soc (2010) 0.88
The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses. J Virol (2013) 0.80
Interaction of the most membranotropic region of the HCV E2 envelope glycoprotein with membranes. Biophysical characterization. Biophys J (2008) 0.78
Lysophosphatidylcholine inhibits membrane-associated SNARE complex disassembly. J Cell Mol Med (2012) 0.75
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
Membrane fusion. Cell (2003) 7.68
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell (2001) 5.65
Protein-lipid interplay in fusion and fission of biological membranes. Annu Rev Biochem (2003) 4.77
The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol (2003) 4.21
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J (2004) 4.05
Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature (2004) 4.02
Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys J (1993) 3.82
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Stalk model of membrane fusion: solution of energy crisis. Biophys J (2002) 3.51
Structural basis for membrane fusion by enveloped viruses. Mol Membr Biol (1999) 3.26
Membrane fusion: stalk model revisited. Biophys J (2002) 2.83
An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids. J Cell Biol (1997) 2.73
The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion. Biophys J (1999) 2.30
Cholesterol is required for infection by Semliki Forest virus. J Cell Biol (1991) 2.24
Lysolipids reversibly inhibit Ca(2+)-, GTP- and pH-dependent fusion of biological membranes. FEBS Lett (1993) 2.11
Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology (2000) 2.09
Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J (1994) 1.99
Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol (1981) 1.90
Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol (2002) 1.83
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
The machinery for flavivirus fusion with host cell membranes. Curr Opin Microbiol (2001) 1.77
Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol (1999) 1.69
Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry (1990) 1.59
Virology: a class act. Nature (2004) 1.54
Membrane fusion: a structural perspective on the interplay of lipids and proteins. Curr Opin Struct Biol (2003) 1.52
Control of baculovirus gp64-induced syncytium formation by membrane lipid composition. J Virol (1995) 1.51
Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes. Biochemistry (1989) 1.46
Specific roles for lipids in virus fusion and exit. Examples from the alphaviruses. Subcell Biochem (2000) 1.46
Involvement of lipids in different steps of the flavivirus fusion mechanism. J Virol (2003) 1.42
Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger. J Biol Chem (1993) 1.39
Reconstitution of membrane fusion sites. A total internal reflection fluorescence microscopy study of influenza hemagglutinin-mediated membrane fusion. J Biol Chem (1994) 1.35
Rabies virus-induced membrane fusion pathway. J Cell Biol (2000) 1.32
Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol (2001) 1.23
Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine. J Biol Chem (1995) 1.21
Characterization of a membrane-associated trimeric low-pH-induced Form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J Virol (2004) 1.19
Structure and energy of fusion stalks: the role of membrane edges. Biophys J (2002) 1.14
Coupling of cholesterol and cone-shaped lipids in bilayers augments membrane permeabilization by the cholesterol-specific toxins streptolysin O and Vibrio cholerae cytolysin. J Biol Chem (2001) 1.07
Lipids favoring inverted phase enhance the ability of aerolysin to permeabilize liposome bilayers. Biochemistry (2000) 1.04
Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. J Virol (1995) 0.99
How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus. Virology (1997) 0.98
Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism. Biochemistry (2001) 0.95
Structural surprises from the flaviviruses and alphaviruses. Mol Cell (2002) 0.91
Lysophosphatidylcholine inhibits vesicles fusion induced by the NH2-terminal extremity of SIV/HIV fusogenic proteins. Biochim Biophys Acta (1995) 0.90
Protein-induced fusion can be modulated by target membrane lipids through a structural switch at the level of the fusion peptide. J Biol Chem (2000) 0.90
Lysophosphatidylcholine mediates the mode of insertion of the NH2-terminal SIV fusion peptide into the lipid bilayer. FEBS Lett (1993) 0.88
A conformational analysis study of the interaction of amiodarone and cholesterol with lysophosphatidylcholine. Biochem Pharmacol (1991) 0.77
Molecular interactions in the hydrogen belts of membranes. Glucose-6-phosphatase, lysophosphatidylcholine, and cholesterol. Biochim Biophys Acta (1984) 0.77
Lysolipids do not inhibit influenza virus fusion by interaction with hemagglutinin. J Biol Chem (2002) 0.77
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J (2004) 4.05
Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol (2006) 2.33
Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol (2002) 1.95
Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol (2003) 1.90
Flavivirus membrane fusion. J Gen Virol (2006) 1.87
Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol (2008) 1.83
Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol (2002) 1.83
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J Virol (2002) 1.48
Involvement of lipids in different steps of the flavivirus fusion mechanism. J Virol (2003) 1.42
Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol (2003) 1.38
Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog (2007) 1.37
Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J Virol (2003) 1.28
Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc Natl Acad Sci U S A (2004) 1.23
Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine (2005) 1.23
Tick-borne encephalitis from eating goat cheese in a mountain region of Austria. Emerg Infect Dis (2009) 1.22
Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies. J Virol (2007) 1.21
Characterization of a membrane-associated trimeric low-pH-induced Form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J Virol (2004) 1.19
Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus. J Virol (2003) 1.17
Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C. J Virol (2003) 1.15
Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology (2003) 1.06
Differences in the postfusion conformations of full-length and truncated class II fusion protein E of tick-borne encephalitis virus. J Virol (2005) 0.99
Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles. J Virol (2004) 0.97
Molecular mechanisms of flavivirus membrane fusion. Amino Acids (2009) 0.97
Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine (2009) 0.97
Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog (2013) 0.97
Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice. J Virol (2010) 0.95
Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years. Vaccine (2010) 0.95
Tick-borne encephalitis in childhood--consensus 2004. Wien Med Wochenschr (2004) 0.94
The unique transmembrane hairpin of flavivirus fusion protein E is essential for membrane fusion. J Virol (2011) 0.94
Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS One (2012) 0.94
Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E. J Virol (2009) 0.94
Mutational analysis of the zippering reaction during flavivirus membrane fusion. J Virol (2011) 0.92
Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. J Gen Virol (2005) 0.89
Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia. Int J Med Microbiol (2006) 0.87
Mechanistic insights into the impairment of memory B cells and antibody production in the elderly. Age (Dordr) (2012) 0.84
Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria. Vaccine (2007) 0.83
Selection and analysis of mutations in an encephalomyocarditis virus internal ribosome entry site that improve the efficiency of a bicistronic flavivirus construct. J Virol (2007) 0.82
Entry functions and antigenic structure of flavivirus envelope proteins. Novartis Found Symp (2006) 0.79
Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice. J Virol (2013) 0.78
Seroprevalence of tick-borne encephalitis (TBE) in naturally exposed monkeys (Macaca sylvanus) and sheep and prevalence of TBE virus in ticks in a TBE endemic area in Germany. Ticks Tick Borne Dis (2010) 0.78
Influenza A and B Viruses but Not MERS-CoV in Hajj Pilgrims, Austria, 2014. Emerg Infect Dis (2015) 0.78
The membrane-proximal "stem" region increases the stability of the flavivirus E protein postfusion trimer and modulates its structure. J Virol (2013) 0.77
Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 0.76